Summary of Study ST002768
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001725. The data can be accessed directly via it's Project DOI: 10.21228/M8QX5M This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002768 |
Study Title | Dysregulation of neural activity and microglia function following exposure to the global environmental contaminant perfluorooctane sulfonate (PFOS) |
Study Summary | Humans are chronically exposed to complex chemical mixtures and, correspondingly, researchers are disentangling the contribution of different contaminants to human neuropathologies. Per- and polyfluoroalkyl substances (PFAS) are biopersistent pollutants and, due to their diverse applications, have become global contaminants. Perfluorooctane sulfonate (PFOS), a prevalent PFAS congener, impairs humoral immunity; however, its impact on innate immunity is unclear. Given the critical roles of innate immune cells, namely microglia, in brain development and homeostasis, we asked whether exposure adversely affects microglial function. Herein, we demonstrate developmental PFOS exposure produces microglial activation and upregulation of the microglia activation gene p2ry12. PFOS-induced microglial activation heightened microglial responses to brain injury, in the absence of increased cell death or inflammation. Use of the photoconvertible calcium indicator CaMPARI revealed PFOS exposure heightened neural activity, while optogenetic silencing of neurons was sufficient to normalize microglial responses to injury. Through an untargeted metabolome wide association study (MWAS), we further determined that PFOS-exposed larvae exhibit significant neurochemical imbalances. Exposure to the perfluorooctanoic acid, an immunotoxic PFAS, did not alter neuronal activity or microglial behavior, further supporting a role for neural activity as a critical modifier of microglial function. Together, this study reveals how contaminant-induced changes in brain activity can shape brain health. |
Institute | Brown University |
Last Name | Paquette |
First Name | Shannon |
Address | 70 Ship Street |
shannon_paquette@brown.edu | |
Phone | 4018636125 |
Submit Date | 2022-09-28 |
Raw Data Available | Yes |
Raw Data File Type(s) | cdf |
Analysis Type Detail | LC-MS |
Release Date | 2023-09-28 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001725 |
Project DOI: | doi: 10.21228/M8QX5M |
Project Title: | Targeted Analysis of PFOS in Larval Zebrafish using LC-HRMS & Untargeted Metabolome Wide Association Study (MWAS) |
Project Summary: | Humans are chronically exposed to complex chemical mixtures and, correspondingly, researchers are disentangling the contribution of different contaminants to human neuropathologies. Per- and polyfluoroalkyl substances (PFAS) are biopersistent pollutants and, due to their diverse applications, have become global contaminants. Perfluorooctane sulfonate (PFOS), a prevalent PFAS congener, impairs humoral immunity; however, its impact on innate immunity is unclear. Given the critical roles of innate immune cells, namely microglia, in brain development and homeostasis, we asked whether exposure adversely affects microglial function. Herein, we demonstrate developmental PFOS exposure produces microglial activation and upregulation of the microglia activation gene p2ry12. PFOS-induced microglial activation heightened microglial responses to brain injury, in the absence of increased cell death or inflammation. Use of the photoconvertible calcium indicator CaMPARI revealed PFOS exposure heightened neural activity, while optogenetic silencing of neurons was sufficient to normalize microglial responses to injury. Through an untargeted metabolome wide association study (MWAS), we further determined that PFOS-exposed larvae exhibit significant neurochemical imbalances. Exposure to the perfluorooctanoic acid, an immunotoxic PFAS, did not alter neuronal activity or microglial behavior, further supporting a role for neural activity as a critical modifier of microglial function. Together, this study reveals how contaminant-induced changes in brain activity can shape brain health. |
Institute: | Brown University |
Department: | Pathology and Laboratory Medicine |
Last Name: | Paquette |
First Name: | Shannon |
Address: | 70 Ship Street |
Email: | shannon_paquette@brown.edu |
Phone: | 4018636125 |
Funding Source: | NSF Major Research Instrumentation (MRI) award |
Subject:
Subject ID: | SU002875 |
Subject Type: | Fish |
Subject Species: | Danio rerio |
Taxonomy ID: | 7955 |
Age Or Age Range: | 24-120 hours post-fertilization |
Factors:
Subject type: Fish; Subject species: Danio rerio (Factor headings shown in green)
mb_sample_id | local_sample_id | Treatment |
---|---|---|
SA293392 | PFOS32_72hpf_F_C18.cdf | 32uM PFOS |
SA293393 | PFOS32_72hpf_E_C18.cdf | 32uM PFOS |
SA293394 | PFOS32_72hpf_D_C18.cdf | 32uM PFOS |
SA293395 | PFOS32_72hpf_G_C18.cdf | 32uM PFOS |
SA293396 | PFOS32_72hpf_I_C18.cdf | 32uM PFOS |
SA293397 | PFOS32_72hpf_A.cdf | 32uM PFOS |
SA293398 | PFOS32_72hpf_B.cdf | 32uM PFOS |
SA293399 | PFOS32_72hpf_B_C18.cdf | 32uM PFOS |
SA293400 | PFOS32_72hpf_H_C18.cdf | 32uM PFOS |
SA293401 | PFOS32_72hpf_C_C18.cdf | 32uM PFOS |
SA293402 | PFOS32_72hpf_G.cdf | 32uM PFOS |
SA293403 | PFOS32_72hpf_H.cdf | 32uM PFOS |
SA293404 | PFOS32_72hpf_I.cdf | 32uM PFOS |
SA293405 | PFOS32_72hpf_E.cdf | 32uM PFOS |
SA293406 | PFOS32_72hpf_F.cdf | 32uM PFOS |
SA293407 | PFOS32_72hpf_C.cdf | 32uM PFOS |
SA293408 | PFOS32_72hpf_A_C18.cdf | 32uM PFOS |
SA293409 | PFOS32_72hpf_D.cdf | 32uM PFOS |
SA293410 | DMSO_72hpf_G.cdf | DMSO |
SA293411 | DMSO_72hpf_H.cdf | DMSO |
SA293412 | DMSO_72hpf_I.cdf | DMSO |
SA293413 | DMSO_72hpf_F.cdf | DMSO |
SA293414 | DMSO_72hpf_A.cdf | DMSO |
SA293415 | DMSO_72hpf_E_C18.cdf | DMSO |
SA293416 | DMSO_72hpf_F_C18.cdf | DMSO |
SA293417 | DMSO_72hpf_D_C18.cdf | DMSO |
SA293418 | DMSO_72hpf_C_C18.cdf | DMSO |
SA293419 | DMSO_72hpf_B_C18.cdf | DMSO |
SA293420 | DMSO_72hpf_G_C18.cdf | DMSO |
SA293421 | DMSO_72hpf_H_C18.cdf | DMSO |
SA293422 | DMSO_72hpf_C.cdf | DMSO |
SA293423 | DMSO_72hpf_D.cdf | DMSO |
SA293424 | DMSO_72hpf_B.cdf | DMSO |
SA293425 | DMSO_72hpf_A_C18.cdf | DMSO |
SA293426 | DMSO_72hpf_I_C18.cdf | DMSO |
SA293427 | DMSO_72hpf_E.cdf | DMSO |
Showing results 1 to 36 of 36 |
Collection:
Collection ID: | CO002868 |
Collection Summary: | 3 dpf zebrafish larvae were immobilized on ice for 4 minutes. While on ice, larval heads were removed from the body by cutting at a 45 degree angle from the hindbrain to anterior of the heart. Heads (n = 10 per treatment) were snap frozen in liquid nitrogen. |
Sample Type: | Larval Fish Heads/Brain |
Treatment:
Treatment ID: | TR002884 |
Treatment Summary: | Timed spawns were performed for 1 hr. Embryos were collected and screened for embryo quality at 4 hpf. Healthy embryos were placed in 24-well plates at a density of 3 embryos per well. Prior to treatment, PFOS was diluted in egg water to a final concentration of 28 uM. Egg water containing 0.1% DMSO was used as vehicle control. Embryos were dosed with 2 mL of diluted PFOS solution or vehicle control at 4 hpf. The 24-well plates were sealed with parafilm to limit evaporative loss and placed in an incubator (28.5 ± 1°C). Embryos were dechorionated at 24 hpf and statically exposed until the experimental timepoint of interest. |
Sample Preparation:
Sampleprep ID: | SP002881 |
Sampleprep Summary: | Larvae were stored in -80°C freezer until extracted and defrosted at 20°C. 1 mL methanol was added to the centrifuge tube containing the embryos. The samples were sonicated for 90 minutes, vortex mixed 1 minute, and allowed to reach equilibrium for 3 hours at 20°C. Samples were then centrifuged at 3,000 rpm for 10 minutes. The following was added to an LC analysis vial: 50 µL of the methanol extract, 10 µL labelled PFOS internal standard, and 440 µL of a mixture containing 1:1 methanol:water and 2 mM ammonium acetate. The sample extracts were re-analyzed using LC-HRMS to collect untargeted metabolomics data. A 10 µL volume was injected in triplicate onto on the Thermo LC-Orbitrap system described above. Two chromatography separation methods were used, normal and reverse-phase. The normal-phase LC was performed with a HILIC column (Thermo Syncronis HILIC 50 mm X 2.1 mm x 3 µm) at a constant temperature of 25ºC. Mobile phase A contained 2 mM ammonium acetate in acetonitrile and mobile phase B contained 2 mM aqueous ammonium acetate. Metabolites were eluted from the column at a constant flow rate of 0.2 mL/minute using a solvent gradient as follows: equilibrate with 10% B for 1 minute, increase to 65% B for 9 minutes and hold for 3 minutes, decrease to 10% over 1 minute and hold for 1 minute. The reverse-phase LC was performed with a C18 column (Thermo Hypersil Gold Vanquish, 50 mm X 2.1 mm x 1.9 µm) at a constant temperature of 60ºC. Mobile phase A contained 2 mM aqueous ammonium acetate and mobile phase B contained 2 mM ammonium acetate in acetonitrile. Metabolites were eluted from the column at a constant flow rate of 0.5 mL/minute using a mobile phase gradient as follows: equilibration with 2.5% B for 1 minute, increase to 100% B over 11 minutes and held for 2 minutes, and back to 2.5% B over 1 minute and held for 1.5 minutes (total run time 16.5 minutes, data were collected from 0.05 to 12.5 minutes). For both normal and reverse-phase LC, the MS was operated in full scan mode with 120,000 resolution, automatic gain control of 3 × 106, and maximum dwell time of 100 ms. Electrospray ionization was conducted in positive mode for normal-phase and negative mode for reverse phase LC. Ionization was performed at a sheath gas flow of 40 units, auxiliary gas flow of 10 units, sweep gas flow of 2 units, spray voltage of 3.5 kV, 310ºC capillary temperature, funnel radio frequency (RF) level of 35, and 320ºC auxiliary gas heater temperature. |
Combined analysis:
Analysis ID | AN004504 | AN004505 |
---|---|---|
Analysis type | MS | MS |
Chromatography type | Reversed phase | HILIC |
Chromatography system | Thermo Vanquish | Thermo Vanquish |
Column | Thermo Hypersil Gold Vanquish, 50 mm X 2.1 mm x 1.9 µm | Thermo Syncronis HILIC 50 mm X 2.1 mm x 3 µm |
MS Type | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive HF-X Orbitrap | Thermo Q Exactive HF-X Orbitrap |
Ion Mode | NEGATIVE | POSITIVE |
Units | unitless | unitless |
Chromatography:
Chromatography ID: | CH003384 |
Chromatography Summary: | The reverse-phase LC was performed with a C18 column at a constant temperature of 60ºC. Mobile phase A contained 2 mM aqueous ammonium acetate and mobile phase B contained 2 mM ammonium acetate in acetonitrile. Metabolites were eluted from the column at a constant flow rate of 0.5 mL/minute using a mobile phase gradient as follows: equilibration with 2.5% B for 1 minute, increase to 100% B over 11 minutes and held for 2 minutes, and back to 2.5% B over 1 minute and held for 1.5 minutes (total run time 16.5 minutes, data were collected from 0.05 to 12.5 minutes). |
Instrument Name: | Thermo Vanquish |
Column Name: | Thermo Hypersil Gold Vanquish, 50 mm X 2.1 mm x 1.9 µm |
Column Temperature: | 60ºC |
Flow Gradient: | equilibration with 2.5% B for 1 minute, increase to 100% B over 11 minutes and held for 2 minutes, and back to 2.5% B over 1 minute and held for 1.5 minutes (total run time 16.5 minutes, data were collected from 0.05 to 12.5 minutes) |
Flow Rate: | 0.5 mL/minute |
Solvent A: | 2 mM aqueous ammonium acetate |
Solvent B: | 2 mM ammonium acetate in acetonitrile |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH003385 |
Chromatography Summary: | The normal-phase LC was performed with a HILIC column at a constant temperature of 25ºC. Mobile phase A contained 2 mM ammonium acetate in acetonitrile and mobile phase B contained 2 mM aqueous ammonium acetate. Metabolites were eluted from the column at a constant flow rate of 0.2 mL/minute using a solvent gradient as follows: equilibrate with 10% B for 1 minute, increase to 65% B for 9 minutes and hold for 3 minutes, decrease to 10% over 1 minute and hold for 1 minute. |
Instrument Name: | Thermo Vanquish |
Column Name: | Thermo Syncronis HILIC 50 mm X 2.1 mm x 3 µm |
Column Temperature: | 25ºC |
Flow Gradient: | equilibrate with 10% B for 1 minute, increase to 65% B for 9 minutes and hold for 3 minutes, decrease to 10% over 1 minute and hold for 1 minute |
Flow Rate: | 0.2 mL/minute |
Solvent A: | 2 mM ammonium acetate in acetonitrile |
Solvent B: | 2 mM aqueous ammonium acetate |
Chromatography Type: | HILIC |
MS:
MS ID: | MS004251 |
Analysis ID: | AN004504 |
Instrument Name: | Thermo Q Exactive HF-X Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Electrospray ionization was conducted in positive mode for normal-phase and negative mode for reverse phase LC. Ionization was performed at a sheath gas flow of 40 units, auxiliary gas flow of 10 units, sweep gas flow of 2 units, spray voltage of 3.5 kV, 310ºC capillary temperature, funnel radio frequency (RF) level of 35, and 320ºC auxiliary gas heater temperature. |
Ion Mode: | NEGATIVE |
MS ID: | MS004252 |
Analysis ID: | AN004505 |
Instrument Name: | Thermo Q Exactive HF-X Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Electrospray ionization was conducted in positive mode for normal-phase and negative mode for reverse phase LC. Ionization was performed at a sheath gas flow of 40 units, auxiliary gas flow of 10 units, sweep gas flow of 2 units, spray voltage of 3.5 kV, 310ºC capillary temperature, funnel radio frequency (RF) level of 35, and 320ºC auxiliary gas heater temperature. |
Ion Mode: | POSITIVE |